Overview

PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using PI-2620

Status:
Not yet recruiting
Trial end date:
2026-08-01
Target enrollment:
Participant gender:
Summary
We will compare PI-2620 tau PET scans from patients with frontotemporal lobar degeneration (FTLD), patients with non-amnestic presentations of Alzheimer's disease (naAD), and demographically matched cognitively normal seniors.
Phase:
Phase 3
Details
Lead Sponsor:
University of Pennsylvania
Collaborator:
National Institutes of Health (NIH)